Acoustic voice assessment in Parkinson's disease patients submitted to posteroventral pallidotomy

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 1, 2005, Pages 20-25

  Mourão, Lucia Figueiredo ^a,b   De Carvalho Aguiar, Patrícia Maria ^a   Patriani Ferraz, Fernando Antônio ^a   Behlau, Mara Suzana ^a   Ferraz, Henrique Ballalai ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Pallidotomy; Parkinson's disease; Voice

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; DEVICE; DYSARTHRIA; DYSPHONIA; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; ON OFF PHENOMENON; PALLIDOTOMY; PARKINSON DISEASE; POSTEROVENTRAL PALLIDOTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RATING SCALE; SPEECH DISORDER; STATISTICAL ANALYSIS; UNIFIED PARKINSON DISEASE RATING SCALE; VOICE;

EID: 17444394336     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2005000100004     Document Type: Article

References (26)

1. Marsden CD, Parkers JD. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1977;1,345-349.
2. Jiang J, Lin E, Wang J, Hanson DG. Glottographic measures before and after levodopa treatment in Parkinson's disease. Laryngoscope 1999;109,1287-1294.
3. Sanabria J, Ruiz PG, Gutierrez R, et al. The effect of levodopa on vocal function in Parkinon's disease. Clin Neuropharmacol 2001;24,99-102.
4. Gallena S, Smith PJ, Zeffiro T, Ludlow CL. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease. J Speech Lang Hear Res 2001;44,1284-1299.
5. Baron MS, Vitek JL, Bakay ERA, et al. Treatment of advanced Parkinson's disease by posterior Gpi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40,355-366.
6. Laitinen LV, Bergenheim T, Hariz MI. Leksell's posterovenrral pallidotomy in treatment of Parkinson's disease. J Neurosurg 1992;76,53-61.
7. Buck JF, Cooper IS. Speech problems in Parkinsonian patients undergoing anterior choroidal occlusion or chemopallidectomy. J Am Geriat Soc 1956;4,1285-1290.
8. Schulz GM, Peterson T, Sa'pienza CM, Greer M, Friedman W. Voice and Speech characteristics of persons with Parkinon's disease pre- and post-pallidotomy surgery: preliminary findings. J Speech Lang Hear Res 1999;42,1176-1194.
9. Schulz GM, Greer M, Friedman W. Changes in vocal intensity in Parkinson's disease following pallidotomy surgery. J Voice 2000;14,589-606.
10. Ward CD, Gibb WR. Research criteria for Parkinson's disease. In Streifer MB, Korazyn AD, Melamed E (EDS). Advances in Neurology New York: Raven Press. 1990;53:245-249.
11. Aguiar PMC, Ferraz HB, Ferraz FP, Pinto RSR, Hisatugo MK, Andrade LA. Motor performance after posteroventral pallidotomy and VIM-thalamotomy in Parkinson's disease: a one year follow-up study. Arq de Neuropsiquiatr 2000;58,830-835.
12. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In Fahn S, Marsden CD, Calne DB, Goldstein M (EDS) Recent developments in Parkinson's disease 1987;2,153-164.
13. Capit Comittee: Langsten JW, Widner H, Goetz CG, et al. Core assesment program for intracerebral transplantations. Mov Disord. 1992;7:2-13.
14. Ondo WG, Jankovic J, Lai EC, et al. Assessment of motor function after stereotactic pallidotomy. Neurology 1998;50:265-270.
15. Favre J, Burchiel KJ, Taha JM, Hammerstad J. Outcome of unilateral and bilateral pallidotomy for parkinson's disease: patient assessment. Neurosurgery 2000;46,344-355.
16. Iacono RP, Shima F, Lonser RR, Kiniyishi S, Maeda G, Yamada S. The results, indications, and phisiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 1995;36:1118-1127.
17. Larson KK, Ramig LO, Scherer RC. Acoustic and glottographic voice analysis during drug-related fluctuantions in Parkinson disease. J Med Speech Lang Path 1994;2:227-239.
18. Hirose H, Joshita Y. Laryngeal behavior in patients with disorders of central nervous system. In Hirano M, Kirchner JA, Bless DM. (EDS) Neurolaryngology: recent advances Boston: Little Brown; 1987;258-266.
19. Ramig LO, Scherer RC, Titze IR, Ringel SP. Acoustic analysis of voices of patients with neurologic disease: rationale and preliminary data. Ann Otol Rhinol Laryngol 1988;97:164-172.
20. Baker KK, Ramig LO, Luschesi ES, Smith ME. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology 1998;51:1592-1598.
21. Dejonckere PH, Remade M, Fresnel-Elbaz E, Woisard V, Crevier-Buchman L, Millet B. Differential perceptual evaluation of phatological voice quality: reability and correlation with acoustic measurements. Rev Laryngol Otol Rhinol 1996;117:219-224.
22. Kent RD, Weismer G, Kent JF, Vorperian HK, Duffy JR. Acoustic studies of dysarthric speech: methods, progress and potential. J Commun Disord 1999;32:146-186.
23. Schulz GM, Grant MK. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: A review of the literature. J Commun Disord 2000;33:59-88.
24. Wang E, Verhagen Metman L, Bakay R, Arzbaecher J, Bernard B. The effect of unilateral electrostimulation of the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson's Disease: a preliminary report. Clin Linguist Phon 2003;17:283-289.
25. De-Angelis EC, Mourão LF, Ferraz HB, Behlau MS, Pontes PAL, Andrade LAF. Effect of voice rehabilitation on oral communication of Parkinson's disease patients. Acta Neurol Scand 1997;96:199-201.
26. Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive (LSVT) in individuals with Parkinon's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord 2001;16,79-83.